WithdrawnNCT00988481
Topiramate Augmentation in Eating disorders Partial Responders
Medication studyAges 18–60United States
Understand this study
Who could participate?
Listed age limits: 18 years to 60 years.
- Listed locations
- FargoSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateSeptember 2009
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 0
- Sponsor
- Neuropsychiatric Research Institute, Fargo, North Dakota
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 60 Years
- Official registry ID
- NCT00988481
- Official title
Show the full official title
Topiramate Augmentation in Bulimia Nervosa Partial Responders
Recruitment & locations
WithdrawnThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Fargo
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Neuropsychiatric Research Institute, Fargo, North Dakota, a research institute.
Does this study involve medication?
Yes. The study involves medication, including Topiramate.
Who can participate?
Listed age limits: 18 years to 60 years.
Is this study still recruiting?
The registry lists this study as withdrawn.
